April 20, 2026 Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology
April 20, 2026 Swedish Goverment Holds Decision on Norra Karr Exploitation Concession; Directors Exercise Options Injecting New Capital; Investor Relations Engagement
April 20, 2026 Trustpilot Spotlights CoreAge Rx as a Model Wichita Falls Business for Customer Satisfaction
April 20, 2026 Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases